相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches
Kazuishi Kubota et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2019)
HDL and Reverse Cholesterol Transport Basic Mechanisms and Their Roles in Vascular Health and Disease
Mireille Ouimet et al.
CIRCULATION RESEARCH (2019)
HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population A Case-Control Study From the PREVEND Cohort
Sanam Ebtehaj et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
A new method for measuring cholesterol efflux capacity uses stable isotope-labeled, not radioactive-labeled, cholesterol[S]
Tomo Shimizu et al.
JOURNAL OF LIPID RESEARCH (2019)
Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis
Federico Oldoni et al.
CIRCULATION (2018)
HDL functionality in familial hypercholesterolemia: effects of treatment modalities and pharmacological interventions
Shiva Ganjali et al.
DRUG DISCOVERY TODAY (2018)
Target identification of hepcidin production inhibitors by a combination of chemical proteomics and radioactive compound binding assay
Masato Sasaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Molecular basis activation of lecithin: cholesterol acyltransferase by a compound that increases HDL cholesterol
Kelly A. Manthei et al.
ELIFE (2018)
Lecithin: Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31
Lita A. Freeman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cholesterol Uptake Capacity: A New Measure of HDL Functionality for Coronary Risk Assessment
Amane Harada et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2017)
Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies A Scientific Statement From the American Heart Association
Alan Daugherty et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Mapping the Binding Site of BMS-708163 on γ-Secretase with Cleavable Photoprobes
Natalya Gertsik et al.
CELL CHEMICAL BIOLOGY (2017)
Safety and Tolerability of ACP-501, a Recombinant Human Lecithin: Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study
Robert D. Shamburek et al.
CIRCULATION RESEARCH (2016)
Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease
William Herrington et al.
CIRCULATION RESEARCH (2016)
Role of LCAT in Atherosclerosis
Alice Ossoli et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2016)
Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement
Robert D. Shamburek et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2016)
Photoaffinity labeling in target- and binding-site identification
Ewan Smith et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study
Danish Saleheen et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
High-density lipoprotein metabolism, composition, function, and deficiency
Ernst J. Schaefer et al.
CURRENT OPINION IN LIPIDOLOGY (2014)
HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events
Anand Rohatgi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Recent Advances in Target Characterization and Identification by Photoaffinity Probes
Jitapa Sumranjit et al.
MOLECULES (2013)
Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges
Uchechukwu K. Sampson et al.
CURRENT ATHEROSCLEROSIS REPORTS (2012)
HDL functionality
Handrean Soran et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
Small molecule activation of lecithin cholesterol acyltransferase modulates lipoprotein metabolism in mice and hamsters
Zhu Chen et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Plasma lecithin: cholesterol acyltransferase and carotid intima-media thickness in European individuals at high cardiovascular risk
Laura Calabresi et al.
JOURNAL OF LIPID RESEARCH (2011)
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
Amit V. Khera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
AAV8-Mediated Long-Term Expression of Human LCAT Significantly Improves Lipid Profiles in hCETP;Ldlr+/- Mice
Zhu Chen et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2011)
A Tissue-Specific Atlas of Mouse Protein Phosphorylation and Expression
Edward L. Huttlin et al.
CELL (2010)
Functional Lecithin: Cholesterol Acyltransferase Is Not Required for Efficient Atheroprotection in Humans
Laura Calabresi et al.
CIRCULATION (2009)
Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions
E. Van Craeyveld et al.
GENE THERAPY (2009)
Lecithin: cholesterol acyltransferase - from biochemistry to role in cardiovascular disease
Xavier Rousset et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2009)
HDL, ABC transporters, and cholesterol efflux: Implications for the treatment of atherosclerosis
Alan R. Tall et al.
CELL METABOLISM (2008)
Plasma Lecithin: Cholesterol Acyltransferase Activity Is Elevated in Metabolic Syndrome and Is an Independent Marker of Increased Carotid Artery Intima Media Thickness
Robin P. F. Dullaart et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
Philip Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo
SU Naik et al.
CIRCULATION (2006)
Compromised LCAT function is associated with increased atherosclerosis
GK Hovingh et al.
CIRCULATION (2005)
The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins
PJ O'Brien et al.
CLINICAL CHEMISTRY (2005)
Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo
YZ Zhang et al.
CIRCULATION (2003)
Analytical performance of a sandwich enzyme immunoassay for preβ1-HDL in stabilized plasma
T Miida et al.
JOURNAL OF LIPID RESEARCH (2003)
T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice
N Terasaka et al.
FEBS LETTERS (2003)
Transgenic overexpression of human lecithin: cholesterol acyltransferase (LCAT) in mice does not increase aortic cholesterol deposition
JW Furbee et al.
ATHEROSCLEROSIS (2002)
分享论文
